OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 31 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $9,000 | 0.0% | 575 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | +28.6% | 575 | 0.0% | 0.00% | – |
Q2 2019 | $7,000 | -12.5% | 575 | -14.8% | 0.00% | – |
Q1 2019 | $8,000 | -20.0% | 675 | 0.0% | 0.00% | – |
Q4 2018 | $10,000 | -16.7% | 675 | 0.0% | 0.00% | – |
Q3 2018 | $12,000 | +33.3% | 675 | +48.4% | 0.00% | – |
Q2 2018 | $9,000 | 0.0% | 455 | 0.0% | 0.00% | – |
Q1 2018 | $9,000 | -10.0% | 455 | 0.0% | 0.00% | – |
Q4 2017 | $10,000 | -9.1% | 455 | +49.2% | 0.00% | – |
Q3 2017 | $11,000 | – | 305 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fondren Management LP | 186,900 | $1,688,000 | 6.52% |
Mesirow Financial Investment Management, Inc. | 19,780 | $179,000 | 0.84% |
Alambic Investment Management, L.P. | 15,312 | $138,000 | 0.35% |
PERRITT CAPITAL MANAGEMENT INC | 29,500 | $266,000 | 0.20% |
GSA CAPITAL PARTNERS LLP | 13,527 | $122,000 | 0.07% |
American Research & Management Co. | 300 | $3,000 | 0.00% |
Renaissance Technologies | 187,970 | $1,697,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 1,467 | $13,000 | 0.00% |
Lindbrook Capital, LLC | 500 | $5,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 32,521 | $293,000 | 0.00% |